financetom
Business
financetom
/
Business
/
BRIEF-Couche-Tard CEO: We Would Like Full Engagement Versus Just Engagement On Antitrust
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Couche-Tard CEO: We Would Like Full Engagement Versus Just Engagement On Antitrust
Mar 12, 2025 8:39 PM

March 13 (Reuters) - Alimentation Couche-Tard ( ANCTF )

* CEO: I DON'T BELIEVE WE HAVE A STAGNANT BUSINESS IN NORTH

AMERICA, THE EARNINGS RESULTS WE HAVE PUT OUT IN RECENT QUARTERS

COMPARED TO SEVEN & I ARE VERY DIFFERENT

* CHAIRMAN: WE ARE STILL OPEN TO TALKING TO THE ITO FAMILY

* CEO: WE WOULD LIKE FULL ENGAGEMENT VERSUS JUST ENGAGEMENT

ON

ANTITRUST

* CEO: WE HAVE ENJOYED THE DIALOGUE ON ANTITRUST, IT'S BEEN

CONSTRUCTIVE BUT IS TAKING TOO LONG

* CEO: THE JANUARY RESTATEMENT OF OUR OFFER IN YEN IS VERY

SIMILAR

TO OUR U.S. DOLLAR OFFER

* CEO: THE U.S. ANTI-MONOPOLY PROCESS DOES NOT TAKE TWO

YEARS

* CEO: THE PROCESS COULD TAKE 12-24 MONTHS

* CHAIRMAN: IN MEETINGS WITH INVESTORS WE SAID WE DON'T KNOW

EXACTLY WHAT OUR PLAN FOR SEVEN & I'S SUPERSTORES BUSINESS WOULD

BE

* CEO: WE CAN'T HAVE AN INFORMED DECISION ON THE SUPERSTORES

AT

THIS STAGE WITHOUT DUE DILIGENCE

* CHAIRMAN: WE DO NOT INTEND TO CALL OFF OUR BID IF THE

ANTITRUST

PROCESS IS EXTENDED

* CHAIRMAN: THE FRUSTRATION WE FEEL ABOUT THE DEAL IS JUST

ABOUT

THE TIME

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved